CliffBio
small molecule

ARCAPTA NEOHALER

INDACATEROL MALEATE

Loss of exclusivityOctober 2028latest FDA-listed patent expiry
CompanyNovartis →View the full company profile on CliffBio

Drug detail

Brand nameARCAPTA NEOHALER
Active ingredientINDACATEROL MALEATE
StrengthEQ 75MCG BASE
Dosage formPOWDER
RouteINHALATION
ModalitySmall molecule
FDA approvalJuly 2011
Marketing statusDISCN

Listed patents

PatentExpiresType
8479730October 2028product

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ARCAPTA NEOHALER patent cliff — loss of exclusivity October 2028 | CliffBio